Cord Blood America Retains AGORA Investor Relations

Los Angeles, California, UNITED STATES

LOS ANGELES, May 19, 2005 (PRIMEZONE) -- Cord Blood America, Inc. (OTCBB:CBAI), an umbilical cord blood stem cell preservation company, is pleased to announce it has retained the services of AGORA Investor Relations Corp. ("AGORA") ( to provide investor relations services.

The objectives of this agreement are two-fold. The first is to create effective communication between Cord Blood America, its shareholders and the investment community through AGORA's Internet based investor relations system. Effective immediately, a customized and monitored Cord Blood America IR HUB (( will allow the Company and AGORA to communicate with all investors simultaneously and in real-time, while providing shareholders with equal access and complete transparency to all investor relations communications. The IR HUB will also provide one-click access to the Cord Blood America broker fact sheet, company profile, five most recent press releases, e-mail list registration, latest stock quote & chart information and an executive audio address. Also, the IR HUB provides investors with a monitored forum for the purposes of constructive and high-quality discussion about the Company that is free of spam, hype and profanity.

Additionally, AGORA will be fully responsible for creating, implementing and executing an investor relations strategy to significantly improve shareholder communications. This will save management considerable time, effort and expense; and allow them to focus on core business operations.

Matthew L. Schissler, Chairman & CEO of Cord Blood America, states, "Given Cord Blood America's tremendous growth this past year, we believe the time has now come to significantly increase our communications with shareholders and the investment community. Our shareholders and Company will benefit greatly from the timely communications and corporate updates, as well as the increased exposure provided by our relationship with AGORA."

For all future Cord Blood America investor relations needs, investors are asked to visit the Cord Blood America IR HUB at . There they can post questions and receive answers within the same day, or simply review questions and answers posted by other investors. Alternatively, investors are able to e-mail all questions and correspondence to where they can also request addition to the investor e-mail list to receive all future press releases and updates in real time.

About AGORA Investor Relations Corp.

AGORA Investor Relations Corp. (AGORA) is North America's leading outsourced investor relations firm for small-cap companies. AGORA's exclusive IR HUB delivers two-way investor relations and communications that provides 100% transparency, accessibility, equality and near real-time communications for all shareholders and the investment community. AGORA has specialized in small-cap investor relations since 1997 and is the exclusive provider of all content to the AOL Small Cap Channel.

About Cord Blood America

Cord Blood America (OTCBB:CBAI) is the parent company of Cord Partners, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and life-saving resource for treating a growing number of ailments, including cancer, leukemia, or blood and immune disorders. For more information on how this precious lifeline can benefit your family, visit

Forward-Looking Statements

This release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. Forward-looking statements include, without limitation, our ability to increase income streams, to grow revenue and earnings, and to obtain additional cord blood banking revenue streams. These statements are only predictions and are subject to certain risks, uncertainties and assumptions, which are identified and described in the Company's public filings with the Securities and Exchange Commission.


Contact Data